1	Pautar	pautar	VMN0000	-	-	0-6	79_ANS_clinical_caseMIR	SENT1	-	-
2	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	7-18	79_ANS_clinical_caseMIR	SENT1	-	-
3	con	con	SPS00	C0332287	atributo	19-22	79_ANS_clinical_caseMIR	SENT1	-	-
4	alfametildopa	alfametildopa	NCFS000	-	-	23-36	79_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
5	.	.	Fp	-	-	36-37	79_ANS_clinical_caseMIR	SENT1	-	-

1	Recomendar	recomendar	VMN0000	-	-	0-10	79_ANS_clinical_caseMIR	SENT2	-	-
2	dieta	dieta	NCFS000	C2930544_1	hallazgo_1	11-16	79_ANS_clinical_caseMIR	SENT2	-	-
3	hipocalórica	hipocalórica		C2930544_2	hallazgo_2	17-29	79_ANS_clinical_caseMIR	SENT2	-	-
4	y	y	CC	C1706368	calificador	30-31	79_ANS_clinical_caseMIR	SENT2	-	-
5	reducir	reducir	VMN0000	-	-	32-39	79_ANS_clinical_caseMIR	SENT2	-	-
6	ingesta	ingesta	NCFS000	-	-	40-47	79_ANS_clinical_caseMIR	SENT2	-	-
7	de	de	SPS00	C0332285	atributo	48-50	79_ANS_clinical_caseMIR	SENT2	-	-
8	sal	sal	NCFS000	C0037494	producto	51-54	79_ANS_clinical_caseMIR	SENT2	-	-
9	.	.	Fp	-	-	54-55	79_ANS_clinical_caseMIR	SENT2	-	-

1	Diagnóstico	diagnóstico	NCMS000	C0011900	entidad_observable	0-11	79_ANS_clinical_caseMIR	SENT3	-	-
2	de	de	SPS00	C0332285	atributo	12-14	79_ANS_clinical_caseMIR	SENT3	-	-
3	preeclampsia	preeclampsia	NC00SC0	C0032914_1	trastorno_1	15-27	79_ANS_clinical_caseMIR	SENT3	B-Grp_Enfermedad	-
4	.	.	Fp	-	-	27-28	79_ANS_clinical_caseMIR	SENT3	-	-

1	Reposo	reposo	NCMS000	-	-	29-35	79_ANS_clinical_caseMIR	SENT4	-	-
2	y	y	CC	C1706368	calificador	36-37	79_ANS_clinical_caseMIR	SENT4	-	-
3	tratamiento	tratamiento	NCMS000	C0585941_1	procedimiento_1	38-49	79_ANS_clinical_caseMIR	SENT4	-	-
4	antihipertensivo	antihipertensivo	AQ0MS0	C0585941_2	procedimiento_2	50-66	79_ANS_clinical_caseMIR	SENT4	B-Grp_Medicamento	-
5	.	.	Fp	-	-	66-67	79_ANS_clinical_caseMIR	SENT4	-	-

1	Dado	dar	VMP00SM	C1947971	calificador	0-4	79_ANS_clinical_caseMIR	SENT5	-	-
2	que	que	PR0CN000	-	-	5-8	79_ANS_clinical_caseMIR	SENT5	-	-
3	no	no	RN	C1298908	calificador	9-11	79_ANS_clinical_caseMIR	SENT5	-	-
4	existe	existir	VMIP3S0	-	-	12-18	79_ANS_clinical_caseMIR	SENT5	-	-
5	patología	patología	NCFS000	C0030664	calificador	19-28	79_ANS_clinical_caseMIR	SENT5	-	Negacion
6	,	,	Fc	-	-	28-29	79_ANS_clinical_caseMIR	SENT5	-	-
7	se	se	P00CN000	-	-	30-32	79_ANS_clinical_caseMIR	SENT5	-	-
8	debe	deber	VMIP3S0	-	-	33-37	79_ANS_clinical_caseMIR	SENT5	-	-
9	continuar	continuar	VMN0000	-	-	38-47	79_ANS_clinical_caseMIR	SENT5	-	-
10	con	con	SPS00	C0332287	atributo	48-51	79_ANS_clinical_caseMIR	SENT5	-	-
11	los	el	DA0MP0	-	-	52-55	79_ANS_clinical_caseMIR	SENT5	-	-
12	controles	control	NCMP000	C2587213	atributo	56-65	79_ANS_clinical_caseMIR	SENT5	-	-
13	normales	normal	AQ0CP0	C0205307	calificador	66-74	79_ANS_clinical_caseMIR	SENT5	-	-
14	de	de	SPS00	C0332285	atributo	75-77	79_ANS_clinical_caseMIR	SENT5	-	-
15	la	el	DA0FS0	-	-	78-80	79_ANS_clinical_caseMIR	SENT5	-	-
16	gestación	gestación	NCFS000	C0549206#C0032961#C0549169	hallazgo	81-90	79_ANS_clinical_caseMIR	SENT5	-	-
17	.	.	Fp	-	-	90-91	79_ANS_clinical_caseMIR	SENT5	-	-

1	Solicitar	solicitar	VMN0000	-	-	0-9	79_ANS_clinical_caseMIR	SENT6	-	-
2	analítica	analítica	NCFS000	-	-	10-19	79_ANS_clinical_caseMIR	SENT6	-	-
3	de	de	SPS00	C0332285	atributo	20-22	79_ANS_clinical_caseMIR	SENT6	-	-
4	orina	orina	NCFS000	C0042036	sustancia	23-28	79_ANS_clinical_caseMIR	SENT6	-	-
5	.	.	Fp	-	-	28-29	79_ANS_clinical_caseMIR	SENT6	-	-

